Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
Clinical trial NCT05047523 · TERMINATED
Trial details
- NCT number
- NCT05047523
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2023-06-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.